Medicines (MDCO)/Alnylam (ALNY) to Present Phase 1 Data on siRNA-based PCSK9 Today
Evercore ISI analyst Umer Raffat notes Medicines Co. (NASDAQ: MDCO)/Alnylam Pharma (NASDAQ: ALNY) will present updated Ph 1 data on ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
